Covidien Announces New Surgical Access and Tissue Sealing Devices at SAGES 2012

SAN DIEGO--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of three innovative surgical devices designed to provide significant benefits to surgeons and improve patient outcomes. The three are the Versaport™ bladeless optical 5 mm trocar and two new line extensions to the LigaSure™ 5 mm blunt tip sealer/divider portfolio.

MORE ON THIS TOPIC